David J. Graham et al. JAMA, 2004; 292: 2585 Description of Inception Cohorts for Patients Using...

5
David J. Graham et al. JAMA, 2004; 292: 2585 Description of Inception Cohorts for Patients Using Statin and Fibrate Drug Therapy

Transcript of David J. Graham et al. JAMA, 2004; 292: 2585 Description of Inception Cohorts for Patients Using...

Page 1: David J. Graham et al. JAMA, 2004; 292: 2585 Description of Inception Cohorts for Patients Using Statin and Fibrate Drug Therapy.

David J. Graham et al. JAMA, 2004; 292: 2585

Description of Inception Cohorts for Patients

Using Statin and Fibrate Drug Therapy

Page 2: David J. Graham et al. JAMA, 2004; 292: 2585 Description of Inception Cohorts for Patients Using Statin and Fibrate Drug Therapy.

David J. Graham et al. JAMA, 2004; 292: 2585

Monthly Rate of Prescription Dispensings for Atorvastatin, Cerivastatin, Pravastatin, and

Simvastatin per 10000 Population by Calendar Quarter Within 11 Managed

Care Health Plans

Page 3: David J. Graham et al. JAMA, 2004; 292: 2585 Description of Inception Cohorts for Patients Using Statin and Fibrate Drug Therapy.

David J. Graham et al. JAMA, 2004; 292: 2585

Characteristics of Patients Hospitalized With Rhabdomyolysis

While Taking Statins and Fibrates Alone or in Combination

Page 4: David J. Graham et al. JAMA, 2004; 292: 2585 Description of Inception Cohorts for Patients Using Statin and Fibrate Drug Therapy.

David J. Graham et al. JAMA, 2004; 292: 2585

Rhabdomyolysis per 10000 Person-Years

of Therapy With Lipid-Lowering Drugs Used as Monotherapy or as

Combination Therapy With Another Drug

Page 5: David J. Graham et al. JAMA, 2004; 292: 2585 Description of Inception Cohorts for Patients Using Statin and Fibrate Drug Therapy.

David J. Graham et al. JAMA, 2004; 292: 2585

Daily Dose of Lipid-Lowering Drugs Taken by 24 Patients Hospitalized

With Rhabdomyolysis During Therapy